Attached files

file filename
8-K - FORM 8-K - QUAKER CHEMICAL CORPv408812_8k.htm
EX-99.2 - EXHIBIT 99.2 - QUAKER CHEMICAL CORPv408812_ex99-2.htm

Exhibit 99.1

 

NEWS

 

Contact:

Margaret M. Loebl

Vice President, Chief Financial Officer and Treasurer

loeblm@quakerchem.com

T. 610.832.4160

 

 

 

For Release: Immediate

 

QUAKER CHEMICAL ANNOUNCES FIRST QUARTER 2015 RESULTS

 

·Volume gains and gross margin drive good results despite foreign exchange impact

·Foreign currency exchange negatively impacts sales by 7% and EPS by $0.08 per share

·Strong operating cash flow generation, up $10 million from the prior year period

 

April 29, 2015

 

CONSHOHOCKEN, PA – Quaker Chemical Corporation (NYSE: KWR) today announced net sales of $181.3 million for the first quarter of 2015 compared to the first quarter of 2014 net sales of $181.7 million. Despite year-over-year volume growth in the first quarter of 2015, these gains were offset by $12.1 million, or 7%, of lower net sales due to foreign currency exchange. Earnings per diluted share for the first quarter of 2015 were $0.78 compared to $0.96 for the first quarter of 2014, with non-GAAP earnings per diluted share for the first quarter of 2015 of $0.94 compared to $0.95 for the first quarter of 2014. The key driver in the decrease in reported earnings per diluted share compared to the first quarter of 2014 was a $2.8 million, or $0.21 per diluted share, charge related to the Company’s Venezuelan affiliate, noted below. The Company’s adjusted EBITDA was $23.2 million in the first quarter of 2015 compared to $23.7 million in the first quarter of 2014. Overall, changes in foreign exchange rates significantly impacted the Company’s first quarter of 2015 reported and non-GAAP results, decreasing net income approximately $1.1 million, or $0.08 per diluted share.

 

Michael F. Barry, Chairman, Chief Executive Officer and President commented, “We are pleased with our results this quarter in spite of a difficult global market with significant foreign exchange headwinds. Lower oil prices and a stronger U.S. Dollar have changed the dynamics of our customers’ markets and have negatively impacted both our top and bottom lines. However, our continued market share gains and recent acquisitions have helped us achieve stable sales and earnings despite these extreme changes in our environment.”

 

Mr. Barry continued, “Looking forward, we expect a challenging, but stable, market environment in many of the countries in which we operate, along with a continued strong U.S. Dollar. However, we remain committed to our strategy and believe our ability to increase market share and leverage our acquisitions will more than offset these market and exchange rate challenges. In addition, our strong cash flow and balance sheet will allow us to continue to pursue our key strategic initiatives and future acquisitions, which we believe will add significant shareholder value. Overall, I remain confident in our future and expect 2015 to be another good year for Quaker with increased earnings for the sixth consecutive year.”

 

 

 

 

 

Quaker Chemical Corporation

One Quaker Park, 901 E. Hector Street, Conshohocken, PA 19428-2380 USA

P: 610.832.4000 F: 610.832.8682

quakerchem.com

 
 

 

First Quarter of 2015 Summary

 

Net sales for the first quarter of 2015 of $181.3 million were generally consistent with net sales for the first quarter of 2014 of $181.7 million. Increases in product volume, including additional sales from acquisitions, were offset by a decrease of $12.1 million, or 7%, due to the negative impacts of foreign currency exchange rate translation.

 

Gross profit increased $1.2 million, or 2%, compared to the first quarter of 2014, which was primarily driven by the higher product volume, noted above, and increased gross margin of 36.6% for the first quarter of 2015 compared to 35.8% for the first quarter of 2014.

 

Selling, general and administrative expenses (“SG&A”) increased $2.7 million compared to the first quarter of 2014, which was driven by the net impact of several factors. Specifically, SG&A increased due to additional costs acquired with the Company’s prior year acquisitions, higher labor-related costs, and a first quarter of 2015 charge related to a cost streamlining initiative in South America. These SG&A increases were partially offset by decreases from foreign currency exchange rate translation and a first quarter of 2014 cost related to an amendment to the Company’s pension plan in the United Kingdom (“U.K.”).

 

Other expense was approximately $0.2 million in the first quarter of 2015 compared to $0.5 million in the first quarter of 2014. In both quarters, the Company’s other expense was primarily driven by foreign exchange transactional losses, with a lower net loss in the first quarter of 2015 driving the year-over-year comparison.

 

Interest expense was $0.1 million higher in the first quarter of 2015 compared to the first quarter of 2014, primarily due to higher average borrowings outstanding in the current quarter to fund the Company’s recent acquisition activity. Interest income was $0.1 million lower in the first quarter of 2015 compared to the first quarter of 2014, primarily due to interest received on a non-income tax credit in the first quarter of 2014.

 

The Company’s effective tax rates for the first quarters of 2015 and 2014 were 30.8% and 34.8%, respectively. The primary contributors to the decrease in the current quarter’s effective tax rate were lower changes in reserves related to uncertain tax positions in the first quarter of 2015 and certain one-time items that increased the first quarter of 2014’s effective tax rate. We currently estimate the full year 2015 effective tax rate will approximate 30%.

 

Equity in net income of associated companies (“equity income”) decreased by $2.5 million in the first quarter of 2015 compared to the first quarter of 2014, which was primarily due to the current quarter’s currency conversion charge recorded at the Company’s Venezuelan affiliate. Due to recent changes in Venezuela’s foreign exchange markets and controls, the Company re-assessed its Venezuelan affiliate’s access to U.S. Dollars and its ability to import or trade under the existing exchange markets as of March 31, 2015, which resulted in the first quarter of 2015 charge, noted above. In addition, equity income includes the Company’s interest in a captive insurance company, which was consistent in the current and prior year quarters.

 

The $0.4 million decrease in net income attributable to noncontrolling interest in the first quarter of 2015 compared to the first quarter of 2014 was primarily due to the Company’s second quarter of 2014 acquisition of the noncontrolling interest in its Australian affiliate.

 

Changes in foreign exchange rates negatively impacted the first quarter of 2015 net income by approximately $1.1 million, or $0.08 per diluted share.

 

Balance Sheet and Cash Flow Items

 

The Company had net operating cash flows of approximately $8.1 million for the first quarter of 2015, a $9.9 million increase compared to cash outflows of $1.8 million in the first quarter of 2014. The increase in net operating cash flows primarily relates to lower cash invested in the Company’s working capital during the first quarter of 2015 due to improved working capital management. Overall, the Company’s liquidity remains strong, with net debt of $8.8 million as of March 31, 2015 and a consolidated leverage ratio that continues to be less than one times EBITDA.

 

- more -
 

 

Non-GAAP Measures

 

Included in this public release are non-GAAP (unaudited) financial measures of non-GAAP earnings per diluted share and adjusted EBITDA. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader’s understanding of the financial performance of the Company, are more indicative of future operating performance of the Company, and facilitate a better comparison among fiscal periods, as the non-GAAP financial measures exclude items that are not considered core to the Company’s operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP.

 

The following are reconciliations between the non-GAAP (unaudited) financial measures of non-GAAP earnings per diluted share and adjusted EBITDA to their most directly comparable GAAP (unaudited) financial measures:

 

  

Three Months Ended

March 31,

 
   2015   2014 
GAAP earnings per diluted share attributable to Quaker Chemical Corporation common shareholders  $0.78   $0.96 
Equity income in a captive insurance company per diluted share   (0.06)   (0.06)
U.K. pension plan amendment per diluted share       0.05 
Cost streamlining initiatives per diluted share   0.01     
Currency conversion impact of the Venezuelan Bolivar Fuerte per diluted share   0.21     
Non-GAAP earnings per diluted share  $0.94   $0.95 

  

  

Three Months Ended

March 31,

 
   2015   2014 
Net income attributable to Quaker Chemical Corporation  $10,378   $12,730 
Depreciation and amortization   4,698    3,888 
Interest expense   587    525 
Taxes on income before equity in net income of associated companies   5,359    6,546 
Equity income in a captive insurance company   (795)   (846)
U.K. pension plan amendment       902 
Cost streamlining initiatives   173     
Currency conversion impact of the Venezuelan Bolivar Fuerte   2,806     
Adjusted EBITDA  $23,206   $23,745 

  

Forward-Looking Statements

 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements. A major risk is that the Company’s demand is largely derived from the demand for its customers’ products, which subjects the Company to downturns in a customer’s business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, future terrorist attacks and other acts of violence. Other factors could also adversely affect us. Therefore, we caution you not to place undue reliance on our forward-looking statements. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.

 

- more -
 

 

Conference Call

 

As previously announced, Quaker Chemical’s investor conference call to discuss the first quarter of 2015 results is scheduled for April 30, 2015 at 8:30 a.m. (ET). A live webcast of the conference call, together with supplemental information, can be accessed through the Company’s Investor Relations website at http://www.quakerchem.com. You can also access the conference call by dialing 877-269-7756.

  

About Quaker

 

Quaker Chemical is a leading global provider of process fluids, chemical specialties, and technical expertise to a wide range of industries, including steel, aluminum, automotive, mining, aerospace, tube and pipe, cans, and others.  For nearly 100 years, Quaker has helped customers around the world achieve production efficiency, improve product quality, and lower costs through a combination of innovative technology, process knowledge, and customized services. Headquartered in Conshohocken, Pennsylvania USA, Quaker serves businesses worldwide with a network of dedicated and experienced professionals whose mission is to make a difference.

 

- more -
 

 

Quaker Chemical Corporation

 

Condensed Consolidated Statements of Income

 

(Dollars in thousands, except per share data)

 

 

   (Unaudited) 
   Three Months Ended March 31, 
   2015   2014 
         
Net sales  $181,330   $181,674 
           
Cost of goods sold   115,002    116,560 
           
Gross profit   66,328    65,114 
%   36.6%   35.8%
           
Selling, general and administrative expenses   48,464    45,741 
           
Operating income   17,864    19,373 
%   9.9%   10.7%
           
Other expense, net   (194)   (473)
Interest expense   (587)   (525)
Interest income   320    453 
Income before taxes and equity in net income of associated companies   17,403    18,828 
           
Taxes on income before equity in net income of associated companies   5,359    6,546 
Income before equity in net income of associated companies   12,044    12,282 
           
Equity in net (loss) income of associated companies   (1,437)   1,027 
           
Net income   10,607    13,309 
           
Less: Net income attributable to noncontrolling interest   229    579 
           
Net income attributable to Quaker Chemical Corporation  $10,378   $12,730 
%   5.7%   7.0%
           
Per share data:          
Net income attributable to Quaker Chemical Corporation Common Shareholders - basic  $0.78   $0.96 
Net income attributable to Quaker Chemical Corporation Common Shareholders - diluted  $0.78   $0.96 

  

- more -
 

 

Quaker Chemical Corporation

 

Condensed Consolidated Balance Sheets

 

(Dollars in thousands, except par value and share amounts)

 

 

   (Unaudited) 
   March 31,   December 31, 
   2015   2014 
ASSETS          
           
Current assets          
Cash and cash equivalents  $64,338   $64,731 
Accounts receivable, net   180,402    189,484 
Inventories, net   77,176    77,708 
Prepaid expenses and other current assets   18,282    19,595 
Total current assets   340,198    351,518 
           
Property, plant and equipment, net   81,865    85,763 
Goodwill   75,169    77,933 
Other intangible assets, net   67,153    70,408 
Investments in associated companies   20,536    21,751 
Deferred income taxes   21,770    24,411 
Other assets   33,586    33,742 
Total assets  $640,277   $665,526 
           
LIABILITIES AND EQUITY          
           
Current liabilities          
Short-term borrowings and current portion of long-term debt  $401   $403 
Accounts and other payables   71,718    78,977 
Accrued compensation   11,954    19,853 
Other current liabilities   24,711    25,668 
Total current liabilities   108,784    124,901 
Long-term debt   72,698    75,328 
Deferred income taxes   7,558    8,584 
Other non-current liabilities   86,108    91,578 
Total liabilities   275,148    300,391 
           
Equity          
Common stock, $1 par value; authorized 30,000,000 shares; issued and outstanding 2015 - 13,332,472 shares; 2014 - 13,300,891 shares   13,332    13,301 
Capital in excess of par value   100,947    99,056 
Retained earnings   305,902    299,524 
Accumulated other comprehensive loss   (62,971)   (54,406)
Total Quaker shareholders' equity   357,210    357,475 
Noncontrolling interest   7,919    7,660 
Total equity   365,129    365,135 
Total liabilities and equity  $640,277   $665,526 

 

 

 

- more -
 

  

Quaker Chemical Corporation

 

Condensed Consolidated Statements of Cash Flows

 

(Dollars in thousands)

 

         
   (Unaudited) 
   Three Months Ended March 31, 
   2015   2014 
Cash flows from operating activities          
Net income  $10,607   $13,309 
Adjustments to reconcile net income to net cash provided by (used in) operating activities:          
Depreciation   3,071    3,075 
Amortization   1,627    813 
Equity in undistributed earnings of associated companies, net of dividends   1,437    (927)
Deferred compensation and other, net   1,091    2,944 
Stock-based compensation   1,685    1,388 
Gain on disposal of property, plant and equipment   (21)   (48)
Insurance settlements realized   (115)   (337)
Pension and other postretirement benefits   10    (1,665)
Increase (decrease) in cash from changes in current assets and current liabilities, net of acquisitions:          
Accounts receivable   3,428    (13,387)
Inventories   (2,584)   (6,389)
Prepaid expenses and other current assets   (2,634)   (29)
Accounts payable and accrued liabilities   (9,516)   (544)
Net cash provided by (used in) operating activities   8,086    (1,797)
           
Cash flows from investing activities          
Investments in property, plant and equipment   (2,414)   (3,057)
Payments related to acquisitions, net of cash acquired   528    - 
Proceeds from disposition of assets   80    58 
Interest earned on insurance settlements   10    11 
Change in restricted cash, net   105    326 
Net cash used in investing activities   (1,691)   (2,662)
           
Cash flows from financing activities          
Repayment of long-term debt   (1,327)   (232)
Dividends paid   (3,990)   (3,300)
Stock options exercised, other   (50)   (205)
Excess tax benefit related to stock option exercises   287    239 
Net cash used in financing activities   (5,080)   (3,498)
           
Effect of exchange rate changes on cash   (1,708)   (85)
Net decrease in cash and cash equivalents   (393)   (8,042)
Cash and cash equivalents at the beginning of the period   64,731    68,492 
Cash and cash equivalents at the end of the period  $64,338   $60,450